NLS Column

As this year’s Nobel Prize winners were walking into Stockholm City Hall for festivities recently, the temperature was climbing below zero in the December night outside.

The Finnish economy has had difficulties achieving robust growth following the financial crisis. The number of startups in the life science sector is declining and existing companies are struggling to secure funding.

When it comes to life science, one of the strengths of Norway and the Nordics is basic and translational immunology. This is where researchers engineer cells and soluble proteins with the aim of developing new strategies to treat diseases, such as autoimmunity and cancer. 

I have always admired those who can play chess well and really wish I learned to play when I was younger. Lucky for me I have a son who, at the moment, really enjoys the game and goes to a chess club every week.

First, I would like to congratulate all the new Nobel Prize winners awarded by The Royal Swedish Academy of Sciences. Once again, this honorable institution highlights and rewards the scientific excellence that drives civilization forward.


The life science innovation gap between the EU and its global competitors continues to widen while the number of EU regulations affecting the industry is rising. Are we heading in the right direction?